Evidence map›Paper›PMID 35110980›Full record

ArticleGerman medical science : GMS e-journal2021

Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis.

Antje Mevius, Tanja Heidbrede, Patrick Gille, Hans Derk Pannen, Thomas Wilke

Open access · greenAbstract read
In one paragraph

Article in German medical science : GMS e-journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Antje MeviusInstitute for Pharmacoeconomics and Medication Logistics (IPAM) e.V., University of Wismar, Germany.
Tanja HeidbredeUCB Pharma, Monheim, Germany.
Patrick GilleUCB Pharma, Monheim, Germany.
Hans Derk PannenUCB Pharma, Monheim, Germany.
Thomas WilkeInstitute for Pharmacoeconomics and Medication Logistics (IPAM) e.V., University of Wismar, Germany.
UCB Pharma (Germany) · DEWismar University of Applied Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Data AnalysisOsteoporosisAged, 80 and overCross-Sectional StudiesFemaleHumansIncidenceMiddle AgedPostmenopauseQuality of LifeRetrospective Studiesguideline adherencehigh risk of fracturespostmenopausal osteoporosisreal-world treatment

Identifiers

PMID35110980
PMCPMC8778936
OpenAlexW4210773630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.